Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust
- PMID: 22272697
- PMCID: PMC3418668
- DOI: 10.1586/ehm.11.78
Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust
Similar articles
-
Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.Biol Blood Marrow Transplant. 2016 Jan;22(1):96-103. doi: 10.1016/j.bbmt.2015.08.017. Epub 2015 Aug 22. Biol Blood Marrow Transplant. 2016. PMID: 26307344 Review.
-
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.Sci Rep. 2016 Feb 23;6:21757. doi: 10.1038/srep21757. Sci Rep. 2016. PMID: 26902653 Free PMC article.
-
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).Bone Marrow Transplant. 2013 Feb;48(2):220-5. doi: 10.1038/bmt.2012.119. Epub 2012 Jul 9. Bone Marrow Transplant. 2013. PMID: 22773129
-
Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):63-71. doi: 10.1007/s00005-016-0438-2. Epub 2016 Dec 8. Arch Immunol Ther Exp (Warsz). 2016. PMID: 27933342
-
When selecting an HLA mismatched stem cell donor consider donor immune status.Curr Opin Immunol. 2009 Oct;21(5):538-43. doi: 10.1016/j.coi.2009.07.016. Epub 2009 Sep 6. Curr Opin Immunol. 2009. PMID: 19735996 Review.
Cited by
-
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines.Blood Transfus. 2023 Jan;21(1):37-41. doi: 10.2450/2022.0026-22. Epub 2022 Aug 9. Blood Transfus. 2023. PMID: 35969140 Free PMC article. No abstract available.
-
Cell Reversal From a Differentiated to a Stem-Like State at Cancer Initiation.Front Oncol. 2020 Apr 15;10:541. doi: 10.3389/fonc.2020.00541. eCollection 2020. Front Oncol. 2020. PMID: 32351900 Free PMC article.
-
We have a specific duty to maximise the safety of related donors.Blood Transfus. 2012 Oct;10(4):407-10. doi: 10.2450/2012.0042-12. Epub 2012 Jul 12. Blood Transfus. 2012. PMID: 22871822 Free PMC article. No abstract available.
-
Hematopoietic Stem Cell Donors' Experiences of Information and Side-Effects During the First Year After Donation-A Swedish National Study.J Clin Apher. 2025 Aug;40(4):e70050. doi: 10.1002/jca.70050. J Clin Apher. 2025. PMID: 40817620 Free PMC article.
References
-
- Confer D, Robinett P. The US National Marrow Donor Program role in unrelateddonor hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42(Suppl 1):S3–S5. - PubMed
-
- McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R. Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008;48(9):2008–2025. - PubMed
-
- Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet. 1999;353(9152):555. - PubMed
-
- Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604–3611. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical